This would require that all Generic Drugs provided by Medicare Insurers be manufactured in the United States in facilities approved by the FDA. At present, a significant proportion of generic drugs are manufactured in China, India, Israel etc. in Facilities neither Inspected or approved by the US FDA . Some 40 percent of Generic drugs sold in the USA are made in China who does not allow FDA Inspection



